These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 28638739)

  • 1. Ewing sarcoma partial regression without GvHD by chondromodulin-I/HLA-A*02:01-specific allorestricted T cell receptor transgenic T cells.
    Thiel U; Schober SJ; Einspieler I; Kirschner A; Thiede M; Schirmer D; Gall K; Blaeschke F; Schmidt O; Jabar S; Ranft A; Alba Rubío R; Dirksen U; Grunewald TGP; Sorensen PH; Richter GHS; von Lüttichau IT; Busch DH; Burdach SEG
    Oncoimmunology; 2017; 6(5):e1312239. PubMed ID: 28638739
    [No Abstract]   [Full Text] [Related]  

  • 2. Human HLA-A*02:01/CHM1+ allo-restricted T cell receptor transgenic CD8+ T cells specifically inhibit Ewing sarcoma growth in vitro and in vivo.
    Blaeschke F; Thiel U; Kirschner A; Thiede M; Rubio RA; Schirmer D; Kirchner T; Richter GHS; Mall S; Klar R; Riddell S; Busch DH; Krackhardt A; Grunewald TG; Burdach S
    Oncotarget; 2016 Jul; 7(28):43267-43280. PubMed ID: 27281613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lysosome-associated membrane glycoprotein 1 predicts fratricide amongst T cell receptor transgenic CD8+ T cells directed against tumor-associated antigens.
    Kirschner A; Thiede M; Blaeschke F; Richter GH; Gerke JS; Baldauf MC; Grünewald TG; Busch DH; Burdach S; Thiel U
    Oncotarget; 2016 Aug; 7(35):56584-56597. PubMed ID: 27447745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific recognition and inhibition of Ewing tumour growth by antigen-specific allo-restricted cytotoxic T cells.
    Thiel U; Pirson S; Müller-Spahn C; Conrad H; Busch DH; Bernhard H; Burdach S; Richter GH
    Br J Cancer; 2011 Mar; 104(6):948-56. PubMed ID: 21407224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The endochondral bone protein CHM1 sustains an undifferentiated, invasive phenotype, promoting lung metastasis in Ewing sarcoma.
    von Heyking K; Calzada-Wack J; Göllner S; Neff F; Schmidt O; Hensel T; Schirmer D; Fasan A; Esposito I; Müller-Tidow C; Sorensen PH; Burdach S; Richter GHS
    Mol Oncol; 2017 Sep; 11(9):1288-1301. PubMed ID: 28319320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T Cells Directed against the Metastatic Driver Chondromodulin-1 in Ewing Sarcoma: Comparative Engineering with CRISPR/Cas9 vs. Retroviral Gene Transfer for Adoptive Transfer.
    Xue B; von Heyking K; Gassmann H; Poorebrahim M; Thiede M; Schober K; Mautner J; Hauer J; Ruland J; Busch DH; Thiel U; Burdach SEG
    Cancers (Basel); 2022 Nov; 14(22):. PubMed ID: 36428578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pappalysin-1 T cell receptor transgenic allo-restricted T cells kill Ewing sarcoma
    Kirschner A; Thiede M; Grünewald TG; Alba Rubio R; Richter GH; Kirchner T; Busch DH; Burdach S; Thiel U
    Oncoimmunology; 2017; 6(2):e1273301. PubMed ID: 28344885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional analysis of HLA-A*0201/Melan-A peptide multimer+ CD8+ T cells isolated from an HLA-A*0201- donor: exploring tumor antigen allorestricted recognition.
    Dutoit V; Guillaume P; Romero P; Cerottini JC; Valmori D
    Cancer Immun; 2002 Jul; 2():7. PubMed ID: 12747752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monocyte Maturation Mediators Upregulate CD83, ICAM-1 and MHC Class 1 Expression on Ewing's Sarcoma, Enhancing T Cell Cytotoxicity.
    Biele E; Schober SJ; Prexler C; Thiede M; Heyking KV; Gassmann H; Eck J; Xue B; Burdach S; Thiel U
    Cells; 2021 Nov; 10(11):. PubMed ID: 34831294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MHC Class I-Restricted TCR-Transgenic CD4
    Schober SJ; Thiede M; Gassmann H; Prexler C; Xue B; Schirmer D; Wohlleber D; Stein S; Grünewald TGP; Busch DH; Richter GHS; Burdach SEG; Thiel U
    Cells; 2020 Jun; 9(7):. PubMed ID: 32610710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TCR-transgenic T cells and YB-1-based oncolytic virotherapy improve survival in a preclinical Ewing sarcoma xenograft mouse model.
    Schober SJ; Thiede M; Gassmann H; von Ofen AJ; Knoch P; Eck J; Prexler C; Kordass-Wally C; Hauer J; Burdach S; Holm PS; Thiel U
    Front Immunol; 2024; 15():1330868. PubMed ID: 38318175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transgenic antigen-specific, HLA-A*02:01-allo-restricted cytotoxic T cells recognize tumor-associated target antigen STEAP1 with high specificity.
    Schirmer D; Grünewald TG; Klar R; Schmidt O; Wohlleber D; Rubío RA; Uckert W; Thiel U; Bohne F; Busch DH; Krackhardt AM; Burdach S; Richter GH
    Oncoimmunology; 2016 Jun; 5(6):e1175795. PubMed ID: 27471654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allorestricted T lymphocytes with a high avidity T-cell receptor towards NY-ESO-1 have potent anti-tumor activity.
    Krönig H; Hofer K; Conrad H; Guilaume P; Müller J; Schiemann M; Lennerz V; Cosma A; Peschel C; Busch DH; Romero P; Bernhard H
    Int J Cancer; 2009 Aug; 125(3):649-55. PubMed ID: 19444908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor rejection effects of allorestricted tumor peptide-specific CD4(+) T cells on human cervical cancer cell xenograft in nude mice.
    Song Y; Sun W; Weng X; Liang Z; Yu Q; Wang Z; Ouyang L; Chen J; Wu X; Shen G; Wu X
    Cell Transplant; 2012; 21(7):1503-14. PubMed ID: 22525838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human cytotoxic T lymphocytes. III. Large numbers of peripheral blood T cells clonally develop into allorestricted anti-viral cytotoxic T cell populations in vitro.
    Kabelitz D; Herzog WR; Heeg K; Wagner H; Reimann J
    J Mol Cell Immunol; 1987; 3(1):49-60. PubMed ID: 2855406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The fate of donor T-cell receptor transgenic T cells with known host antigen specificity in a graft-versus-host disease model.
    Dey B; Yang YG; Preffer F; Shimizu A; Swenson K; Dombkowski D; Sykes M
    Transplantation; 1999 Jul; 68(1):141-9. PubMed ID: 10428282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A single TCR alpha-chain with dominant peptide recognition in the allorestricted HER2/neu-specific T cell repertoire.
    Liang X; Weigand LU; Schuster IG; Eppinger E; van der Griendt JC; Schub A; Leisegang M; Sommermeyer D; Anderl F; Han Y; Ellwart J; Moosmann A; Busch DH; Uckert W; Peschel C; Krackhardt AM
    J Immunol; 2010 Feb; 184(3):1617-29. PubMed ID: 20042572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of peptide involvement in T cell allorecognition using recombinant HLA class I multimers.
    Whitelegg AM; Oosten LE; Jordan S; Kester M; van Halteren AG; Madrigal JA; Goulmy E; Barber LD
    J Immunol; 2005 Aug; 175(3):1706-14. PubMed ID: 16034111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single T cell receptor-mediated recognition of an identical HIV-derived peptide presented by multiple HLA class I molecules.
    Ueno T; Tomiyama H; Takiguchi M
    J Immunol; 2002 Nov; 169(9):4961-9. PubMed ID: 12391209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. WT1-targeted immunotherapy of leukaemia.
    Xue S; Gao L; Gillmore R; Bendle G; Holler A; Downs AM; Tsallios A; Ramirez F; Ghani Y; Hart D; Alcock S; Tranter A; Stauss HJ; Morris E
    Blood Cells Mol Dis; 2004; 33(3):288-90. PubMed ID: 15528146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.